인공심폐기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Heart Lung Machine Market size is expected to reach USD 6.38 Billion in 2034 from USD 3.32 Billion (2025) growing at a CAGR of 7.54% during 2026-2034.

The global heart lung machine market is witnessing steady growth due to the increasing number of cardiovascular surgeries worldwide. Heart lung machines, also known as cardiopulmonary bypass machines, temporarily take over the function of the heart and lungs during complex cardiac procedures. These machines allow surgeons to perform intricate operations by maintaining blood circulation and oxygenation throughout the procedure.

One of the primary drivers of this market is the rising prevalence of cardiovascular diseases, which remain a leading cause of mortality globally. The growing aging population and increasing number of heart surgeries are contributing to the demand for advanced surgical equipment. In addition, technological advancements in cardiopulmonary bypass systems are improving safety and operational efficiency.

In the coming years, the heart lung machine market is expected to grow as healthcare providers continue to invest in advanced cardiac care technologies. Continuous innovations in surgical equipment and improved patient monitoring systems will enhance procedural outcomes. Expanding healthcare infrastructure and increasing access to specialized cardiac treatment are also expected to support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Oxygenators
• Pumps
• Cannula
• Monitoring Systems
• Heat Exchanger Units
• Blood Reservoir
• Others

By Application

• Coronary Artery Bypass Grafting (CABG)
• Heart Valve Surgeries
• Heart Transplant
• Lung Transplant
• Others

By End-use

• Hospitals
• Cardiac Centers
• Others

COMPANIES PROFILED

• Medtronic, Terumo Europe NV, LivaNova Inc, Getinge, Braile Biomdica, NIPRO, Tianjin Welcome Medical Equipment Co Ltd, ELITE LIFECARE, Hemovent GmbH, MERA Senko Medical Instrument Mfg Co Ltd, Technowood International Pte Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART LUNG MACHINE MARKET: BY COMPONENT 2022-2034 (USD MN and K Units)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Oxygenators Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.3. Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.4. Cannula Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.5. Monitoring Systems Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.6. Heat Exchanger Units Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.7. Blood Reservoir Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL HEART LUNG MACHINE MARKET: BY APPLICATION 2022-2034 (USD MN and K Units)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Coronary Artery Bypass Grafting (CABG) Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.3. Heart Valve Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.4. Heart Transplant Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.5. Lung Transplant Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL HEART LUNG MACHINE MARKET: BY END-USE 2022-2034 (USD MN and K Units)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.3. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL HEART LUNG MACHINE MARKET: BY REGION 2022-2034 (USD MN and K Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.2.1 By Component
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.3.1 By Component
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.4.1 By Component
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.5.1 By Component
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.6.1 By Component
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEART LUNG MACHINE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Terumo Europe NV
  • 9.2.3 LivaNova Inc
  • 9.2.4 Getinge
  • 9.2.5 Braile Biomedica
  • 9.2.6 NIPRO
  • 9.2.7 Tianjin Welcome Medical Equipment Co. Ltd
  • 9.2.8 ELITE LIFECARE
  • 9.2.9 Hemovent GmbH
  • 9.2.10 MERA (Senko Medical Instrument Mfg. Co. Ltd.)
  • 9.2.11 Technowood International Pte. Ltd